Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

Match Group Layoffs 2024: What to Know About the Latest MTCH Job Cuts

Match Group layoffs are a hot topic on Wednesday as the dating website operator is preparing to reduce its headcount due to demand changes.

Can New CEO Kelly Ortberg Save Boeing (BA) Stock?

If Ortberg can get production and quality up at Boeing, then BA stock should fly a lot higher than its current price.

Why is Macrogenics (MGNX) Stock Down 28% Today?

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.

Trade of the Day: Unusual Options Activity Is Bullish for Kosmos Energy (KOS) Stock

With various fundamental forces conspiring in favor of Kosmos Energy, options traders have begun bidding up KOS stock.

Why Is FibroGen (FGEN) Stock Down 44% Today?

FibroGen stock is down on Wednesday as FGEN investors react to the company's failed clinical trials for its pancreatic cancer treatment.

Why Is Nuzee (NUZE) Stock Up 64% Today?

Nuzee stock is up on Wednesday with heavy trading of NUZE shares without any clear news from the coffee and tea company this morning.

Why Is Primech (PMEC) Stock Up 60% Today?

Primech stock is up on Wednesday morning with heavy trading of PMEC shares despite a lack of news from the facilities and stewarding company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!

SIGGRAPH 2024: What to Watch for Nvidia So Far

Nvidia stock is down today despite company CEO Jensen Huang showcasing some impressive projects at work within the chipmaking company.

Should You Buy Intel (INTC) Stock Before Aug. 1?

Here's what investors may want to consider when it comes to Intel's upcoming earnings report and what it may mean for INTC stock.

Symbotic (SYM) Stock Is Down 25% on Weak Guidance. What’s Going on with the AI Darling?

SYM stock is trading about 25% lower after the company reported its earnings and posted weak guidance for the following quarter.

STLA Stock Alert: Stellantis Warns of More Layoffs Ahead. What to Watch.

STLA stock is under pressure today after Stellantis announced plans to reduce its workforce via buyouts and potential layoffs.

PLUG Stock Alert: Plug Power Names New Chief Operating Officer

While Plug Power’s announcement of a new COO got the share price moving, PLUG stock still faces long-term credibility challenges.

Nvidia (NVDA) Stock Falls as Investors Brace for Big Tech Earnings, FOMC Decision

NVDA stock is down today ahead of two key earnings reports due after the bell as well as the Fed policy meeting tomorrow.

JPMorgan Just Issued a Warning on Novavax (NVAX) Stock

Novavax has inked a key vaccine deal with Sanofi, but NVAX stock is down after JPMorgan warned about overvaluation concerns.

Citi Just Raised Its Price Target on Palantir (PLTR) Stock

PLTR is sinking lower today despite price targets hikes from Citi and Jefferies. Both firms raised their respective targets to $28.

SmartRent (SMRT) Stock Plunges 21% as CEO Steps Down

SmartRent stock is falling on Tuesday as SMRT investors react to the resignation of the company's CEO and suspension of its 2024 outlook.

Microsoft Office Outage: Microsoft Investigates Applications, Services Issue

A Microsoft Office outage has workers annoyed as its causing problems with them being able to use the company's services.

SAVA Stock: Cassava Sciences Extends Simufilam Trials as Much as 36 Months

Cassava Sciences has announced plans to extend trials for its Alzheimer’s treatment drug. This news isn't helping SAVA stock.